Nektar Therapeutics SG&A Expense (Quarterly) Insights

Nektar Therapeutics (NKTR)

1.64 +0.13 (+8.61%) USD | NASDAQ | May 08, 09:45

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.

Date	Value
December 31, 2023	17.32M
September 30, 2023	21.15M
June 30, 2023	17.87M
March 31, 2023	21.08M
December 31, 2022	21.94M
September 30, 2022	22.53M
June 30, 2022	20.52M
March 31, 2022	27.34M
December 31, 2021	32.14M
September 30, 2021	29.47M
June 30, 2021	29.56M
March 31, 2021	31.68M
December 31, 2020	27.14M
September 30, 2020	26.98M
June 30, 2020	24.35M
March 31, 2020	26.22M
December 31, 2019	27.14M
September 30, 2019	23.98M
June 30, 2019	22.58M
March 31, 2019	25.01M
December 31, 2018	23.78M
September 30, 2018	18.72M
June 30, 2018	20.26M
March 31, 2018	18.69M
December 31, 2017	12.34M

Date	Value
September 30, 2017	12.06M
June 30, 2017	16.00M
March 31, 2017	11.98M
December 31, 2016	12.76M
September 30, 2016	10.25M
June 30, 2016	11.04M
March 31, 2016	10.23M
December 31, 2015	13.24M
September 30, 2015	9.544M
June 30, 2015	10.18M
March 31, 2015	10.30M
December 31, 2014	12.25M
September 30, 2014	9.13M
June 30, 2014	9.619M
March 31, 2014	9.928M
December 31, 2013	9.832M
September 30, 2013	10.64M
June 30, 2013	9.226M
March 31, 2013	10.83M
December 31, 2012	10.86M
September 30, 2012	10.07M
June 30, 2012	10.27M
March 31, 2012	10.41M
December 31, 2011	11.50M
September 30, 2011	12.35M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

17.32M

Minimum

Dec 2023

32.14M

Maximum

Dec 2021

24.79M

Average

24.35M

Median

Jun 2020

SG&A Expense (Quarterly) Benchmarks